Serstech AB (DE:284)
FRANKFURT:284
284 Stock Chart & Stats
€0.04
<€0.01(1.85%)
At close: 4:00 PM EST
€0.04
<€0.01(1.85%)
Day’s Range― - ―
52-Week Range€0.01 - €0.07
Previous CloseN/A
Volume1.46K
Average Volume (3M)3.50K
Market Cap
€10.39M
Enterprise Value€123.83M
Total Cash (Recent Filing)€787.00K
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta0.14
Next Earnings
Jul 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding254,319,050
10 Day Avg. Volume500
30 Day Avg. Volume3,500
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)3.02
Price to Sales (P/S)3.75
P/FCF Ratio-5.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.02
Revenue Forecast (FY)€6.77M
Bulls Say, Bears Say
Bulls Say
Very Low Leverage / No DebtNo recorded debt across multiple years materially reduces refinancing and interest-rate risk, giving management flexibility to support operations, fund R&D or raise capital on favorable terms. This structural balance-sheet strength supports survival while pursuing a turnaround.
Specialized Handheld Raman Product FocusA focused product set around handheld Raman spectroscopy targets safety, security and industrial use-cases with technical barriers like spectral libraries and instrument accuracy. This specialization creates durable differentiation and potential high switching costs for institutional customers.
Hardware Plus Software And Services Revenue MixA mixed revenue model—hardware sales plus software, spectral libraries and services—supports recurring revenue potential and customer stickiness. Over time this can raise gross margins and predictability versus pure-device sales if software and support adoption scales.
Bears Say
Sharp Revenue ContractionSustained, sizeable revenue declines erode scale and make fixed-cost absorption harder, hurting margins and weakening the business case for continued investment. If demand or distribution problems persist, growth recovery will be harder and unit economics may not improve.
Significant Negative Operating Cash FlowLarge, persistent cash burn forces reliance on external financing or equity dilution to sustain operations. This undermines long-term independence and increases execution risk for product development and market expansion until operations generate consistent positive cash flow.
Deeply Negative Margins And Equity ErosionWidening losses and negative margins have materially reduced shareholders' equity, signaling value destruction. Persistent unprofitability implies weak unit economics and limited operating leverage; without margin recovery, capital base and strategic options will continue to shrink.
284 FAQ
What was Serstech AB’s price range in the past 12 months?
Serstech AB lowest stock price was €0.01 and its highest was €0.07 in the past 12 months.
What is Serstech AB’s market cap?
Serstech AB’s market cap is €10.39M.
When is Serstech AB’s upcoming earnings report date?
Serstech AB’s upcoming earnings report date is Jul 27, 2026 which is in 46 days.
How were Serstech AB’s earnings last quarter?
Serstech AB released its earnings results on Apr 24, 2026. The company reported -€0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.002.
Is Serstech AB overvalued?
According to Wall Street analysts Serstech AB’s price is currently Overvalued.
Does Serstech AB pay dividends?
Serstech AB does not currently pay dividends.
What is Serstech AB’s EPS estimate?
Serstech AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Serstech AB have?
Serstech AB has 254,319,050 shares outstanding.
What happened to Serstech AB’s price movement after its last earnings report?
Serstech AB reported an EPS of -€0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.263%.
Which hedge fund is a major shareholder of Serstech AB?
Currently, no hedge funds are holding shares in DE:284
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Serstech AB
Founded in 2006 and headquartered in Lund, Sweden, Serstech AB is a global provider of advanced chemical identification instruments. The company's offerings include the compact, lightweight, handheld Serstech 100 Indicator, a Raman spectrometer capable of detecting a wide array of chemicals such as explosives, narcotics, toxic industrial chemicals, pharmaceuticals, and chemical warfare agents. Complementing its hardware, Serstech provides ChemDash, a centralized software platform for managing its devices. Furthermore, the product lineup features the innovative Serstech Arx and Arx+ for rapid and precise chemical substance identification, along with the Serstech SERS kit, designed for the quick detection of low-concentration substances and narcotics samples. These solutions are utilized across various critical applications, including explosives detection, CBRN (chemical, biological, radiological, nuclear) and hazmat response, narcotics analysis, and pharmaceutical quality control.
Technical Analysis
Nexam Chemical Holding AB
―
Arctic Minerals AB
―
aXichem AB Class A
―
XP Chemistries AB
―
Ferroamp AB
―